Virology Market Virology Market Forecast to 2028 - COVID19 Impact and Global Analysis By Type (Diagnostic Test, Viral Infection Controlling Techniques, Antiviral Therapeutics, and Interferons); Application (Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Sexually Transmitted Diseases, Urinary Tract Infection, and Others); End User (Hospitals, Diagnostic Laboratories, Pharmaceutical and Biotechnological Companies, and Research and Academic Institutes) and Geography
Current and future Market Scenario
According to our new market research study on “Virology Market to 2028 – Global Analysis and Forecast – by Type, Treatment, and End User,” the market is projected to reach US$ 5,276.48 million by 2028 from US$ 4,108.27 million in 2021; it is expected to register a CAGR of 3.6% from 2021 to 2028.
Based on type, the virology market is sub segmented into diagnostic tests, viral infection controlling techniques, antiviral therapeutics, and interferon's. The diagnostic tests segment is expected to hold the largest market share in 2021. However, the viral infection controlling techniques segment is expected to register the highest CAGR during the forecast period. Virology Market
Market Segments Virology Market By DiagnosticType Test Viral Infection Controlling InterferonsAntiviralTechniquesTherapeutics By End InstitutesResearchBiotechnologicalPharmaceuticalDiagnosticHospitalsUserLaboratoriesandCompaniesandAcademic By SkinApplicationandSoftTissue Infections Respiratory Tract Infections GI Tract Infections Sexually Transmitted Diseases Urinary Tract Infections Others
Leading Players Virology Market Company Profiles in Virology Market are: Abbott Johnson & Johnson Services, Inc. F. Hoffmann-LA Roche Ltd. Thermo Fisher Scientific, Inc. GlaxoSmithKlineIllumina,QiagenInc.SiemensAG Plc Gilead Sciences, Inc. AbbVie, Inc.
Thank You! Virology Market Access Full Research Report at: https://www.theinsightpartners.com/reports/virology-market Thank You!